Trinity Capital trades at a compelling valuation after a year of price declines, with steady earnings and low non-accruals.

Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...

2-Year U.S. Treasury Note Continuous Contract $103.652-0.074-0.07% 5-Year U.S. Treasury Note Continuous Contract $108.422-0.188-0.17% 10-Year U.S. Treasury Note Continuous Contract $111.297-0.250 ...